CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Multiqure SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Multiqure SA
Szczytnicka 11
Green2Day, BusinessLink, 5 pietro
WROCLAW, 50-382  Poland Ticker: MQRMQR
Business Summary
Multiqure SA, formerly known as Pure Biologics SA is a Poland-based biotechnology company engaged in the discovery and development of biologic drug candidates. The Company focuses on research and development activities in oncology and other therapeutic areas. Its technology platforms include antibody- and aptamer-based solutions used in the identification and development of therapeutic candidates targeting specific biological pathways. The Company's pipeline comprises biologic drug candidates, including PB003G, PB004 and PBA-0405. The Company conducts research in immuno-oncology and develops therapeutic programs aimed at addressing unmet medical needs through innovative biologic approaches. In addition to drug discovery activities, it undertakes preclinical research and development work related to the advancement of its therapeutic candidates.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/202612/31/2025Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Management Board Filip J.Jelen 1/1/2010 1/1/2010
Member of the Supervisory Board MiroslawCiucman 8/2/2024 8/2/2024
Member of the Supervisory Board Andrzej MieczyslawKierzkowski 5/7/2019 5/7/2019

Business Names
Business Name
MQR
PUR

General Information
Number of Employees: 7 (As of 3/31/2026)
Outstanding Shares: 225,749,319 (As of 8/5/2026)
Stock Exchange: WAR


Copyright © 2026 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, August 16, 2026